Furthermore, recent reports have shown that a CRP flare response, defined as a transient increase in serum CRP levels after ICI initiation followed by a subsequent decrease below baseline, is associated with better prognosis in renal cell carcinoma, urothelial carcinoma, and lung cancer [26, 34, 36–38]. This evidence concerns the gene CRP and lung cancer.